Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Cyclin D2 expression in chronic myelogenous leukemia].

Jun-min Song1, Dong Xu, Er-jin Fan

  • 1State Key Laboratory of Experimental Hematology, Institute of Hematology, CAMS & PUMC, Tianjin 300020, China.

Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi
|March 3, 2004
PubMed
Summary

Cyclin D2 expression is reduced in chronic myelogenous leukemia (CML) cells with inhibited P210(BCR/ABL) tyrosine kinase. This suggests cyclin D2 may be a downstream signaling molecule contributing to CML cell proliferation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparison of Logistic Regression and Machine Learning Approaches in Predicting Depressive Symptoms: A National-Based Study.

Psychiatry investigation·2025
Same author

Association of Life's Essential 8 with incidence of heart failure modified by depressive symptoms: a prospective cohort study from UK Biobank.

BMC medicine·2025
Same author

Grip strength, genetic predisposition, and Incident Parkinson's disease: a prospective cohort study in the UK Biobank.

NPJ Parkinson's disease·2024
Same author

Multimorbidity patterns and the risk of falls among older adults: a community-based study in China.

BMC geriatrics·2024
Same author

Impact of different anastomosis methods on post-recurrence after intestinal resection for Crohn's disease: A meta-analysis.

World journal of gastrointestinal surgery·2024
Same author

Development of Cost-Effective Fatty Liver Disease Prediction Models in a Chinese Population: Statistical and Machine Learning Approaches.

JMIR formative research·2024

Area of Science:

  • Molecular Biology
  • Oncology
  • Hematology

Context:

  • Chronic myelogenous leukemia (CML) is characterized by the P210(BCR/ABL) tyrosine kinase.
  • Understanding the molecular mechanisms driving CML proliferation is crucial for targeted therapies.

Purpose:

  • To investigate the relationship between cyclin D2 and P210(BCR/ABL) tyrosine kinase in CML.
  • To determine if cyclin D2 expression is affected by P210(BCR/ABL) activity.

Summary:

  • Cyclin D2 expression and S-phase cell count were significantly lower in K562 cells expressing an intrabody against ABL tyrosine kinase domain compared to control K562 cells.
  • RT-PCR, Western blot, and flow cytometry were used to assess cyclin D2 expression and cell cycle progression.

Impact:

Related Experiment Videos

  • Cyclin D2 is identified as a potential downstream signaling molecule of P210(BCR/ABL) in CML.
  • Altered cyclin D2 expression may play a role in the uncontrolled proliferation of CML cells.
  • These findings could inform the development of novel therapeutic strategies targeting cyclin D2 in CML.